ipharmaservicesOct 17REGENERON'S INMAZEB FIRST PRODUCT TO RECEIVE FDA APPROVAL FOR TREATING EBOLA VIRUS
ipharmaservicesOct 9European Commission to purchase 200 million doses of Johnson and Johnson's COVID 19 vaccine
ipharmaservicesOct 3HAS says Gilead's Veklury 'does not improve benefit' for COVID19 patients; EMA to review safety
ipharmaservicesOct 2Novartis presented data of Zolgensma; Roche presented data of Evrysdi at the World Muscle Society
ipharmaservicesSep 25Gilead received the approval of Jyseleca from the European and Japan regulatory authorities for RAGilead has announced that it has received the approval for Jyseleca (filgotinib) from the regulatory authorities in the European Union an...
ipharmaservicesSep 24Pfizer received the approval of Xalkori for ALK-positive anaplastic large cell lymphoma
ipharmaservicesSep 18To strengthen the oncology portfolio, Merck collaborated with Seattle Genetics, and Gilead acquired
ipharmaservicesSep 14Novartis Beovu demonstrated non-inferiority vs. aflibercept in the PEP and superiority in SEP
ipharmaservicesSep 11MSVirtual2020: Novartis and Roche, two Swiss giants, presents robust trial results of their assets
ipharmaservicesSep 11Merck announced trial results of gefapixant in patients with refractory or unexplained chronic cough
ipharmaservicesSep 10FDA approved Trelegy Ellipta for asthma, GSK’s triple therapy is now available for asthma and COPD
ipharmaservicesSep 9Oxford vaccine trials were paused because of safety concerns; AZ said it’s ‘routine’
